Parya Saberi, PharmD

  • Associate Professor, School of Medicine

Biography

Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies in the Department of Medicine at the University of California, San Francisco. She is also an HIV Clinical Pharmacist at Ward 86 (Positive Health Program) at San Francisco General Hospital. Dr. Saberi's is funded by the National Institute of Mental Health through a K23 Mentored Patient-oriented Research Career Development Award. Her current area of research includes adapting technology-based strategies to improve antiretroviral adherence and engagement in HIV Care among HIV-positive youth. These methods include social networking technologies, video-conferencing tools, and text messaging. Additionally, she is involved in the development of an index of engagement in HIV care as well as research regarding retention and adherence to HIV care in South Africa.

Displaying 1 - 72 of 72

  1. Kim HC, Pollack LM, Saberi P, Neilands TB, Arnold EA, Bright DJ, Williams RW, Kegeles SM, Tan JY. Study protocol: a pilot randomised waitlist-controlled trial of a dyadic mobile health intervention for black sexual-minority male couples with HIV in the USA. BMJ Open. 2021 Sep 02; 11(9):e055448. View on Pubmed
  2. Saberi P, Lisha NE, Erguera XA, Hudes ES, Johnson MO, Ruel T, Neilands TB. A Mobile Health App (WYZ) for Engagement in Care and Antiretroviral Therapy Adherence Among Youth and Young Adults Living With HIV: Single-Arm Pilot Intervention Study. JMIR Form Res. 2021 Aug 31; 5(8):e26861. View on Pubmed
  3. Dubé K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C, Sylla L, Louella M, Kosmyna J, Kelly D, Clanton O, Palm D, Campbell DM, Onaiwu MG, Patel H, Ndukwe S, Henley L, Johnson MO, Saberi P, Brown B, Sauceda JA, Sugarman J. Ethics of HIV cure research: an unfinished agenda. BMC Med Ethics. 2021 06 30; 22(1):83. View on Pubmed
  4. Dubé K, Kanazawa J, Campbell C, Boone CA, Maragh-Bass AC, Campbell DM, Agosto-Rosario M, Stockman JK, Diallo DD, Poteat T, Johnson M, Saberi P, Sauceda JA. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry. AIDS Res Hum Retroviruses. 2021 May 31. View on Pubmed
  5. Camp C, Saberi P. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PLoS One. 2021; 16(5):e0251917. View on Pubmed
  6. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):e173-e176. View on Pubmed
  7. Lisha NE, Neilands TB, Erguera XA, Saberi P. Development of the Mobile Technology Vulnerability Scale among Youth and Young Adults Living with HIV. Int J Environ Res Public Health. 2021 04 15; 18(8). View on Pubmed
  8. Caravella McCuistian, Angie R Wootton, Dominique Legnitto-Packard, Valerie A. Gruber, Carol Dawson-Rose, Mallory O. Johnson, Parya Saberi. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 8; 11(4):e042713. View on Pubmed
  9. Saberi P, Campbell CK, Venegas M, Dubé K. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2021 Apr 01. View on Pubmed
  10. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021 Feb; 22(1):14-30. View on Pubmed
  11. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25. View on Pubmed
  12. Kanazawa JT, Saberi P, Sauceda JA, Dubé K. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses. 2021 02; 37(2):75-88. View on Pubmed
  13. Saberi P, Ming K, Scott H, Liu A, Steward W. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020; 15(10):e0240745. View on Pubmed
  14. Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? J Virus Erad. 2020 Nov; 6(4):100017. View on Pubmed
  15. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1607-1611. View on Pubmed
  16. Saberi P, Berrean B, Milionis C, Wong JO, Arnold E. We are family: designing and developing a mobile health application for the San Francisco bay area House Ball and Gay Family communities. Mhealth. 2020; 6:42. View on Pubmed
  17. Dubé K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Res Hum Retroviruses. 2020 12; 36(12):1054-1058. View on Pubmed
  18. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J Virus Erad. 2020 Nov; 6(4):100008. View on Pubmed
  19. Saberi P. Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic. AIDS Behav. 2020 08; 24(8):2232-2235. View on Pubmed
  20. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 07 14; 10(7):e040734. View on Pubmed
  21. Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. Attitudes about community pharmacy access to HIV prevention medications in California. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e179-e183. View on Pubmed
  22. Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses. 2020 07; 36(7):606-615. View on Pubmed
  23. Saberi P, Scott HM. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. J Gen Intern Med. 2020 04; 35(4):1285-1288. View on Pubmed
  24. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2020 Jan; 24(1):284-290. View on Pubmed
  25. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 04; 36(4):324-348. View on Pubmed
  26. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 10; 26(10):1278-1283. View on Pubmed
  27. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 07 16; 9(7):e028522. View on Pubmed
  28. Reeder C, Neilands TB, Palar K, Saberi P. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. J Adolesc Health. 2019 08; 65(2):262-266. View on Pubmed
  29. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020 08; 32(8):931-939. View on Pubmed
  30. Erguera XA, Johnson MO, Neilands TB, Ruel T, Berrean B, Thomas S, Saberi P. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019 05 05; 9(5):e030473. View on Pubmed
  31. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PLoS One. 2019; 14(1):e0210791. View on Pubmed
  32. Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L. The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219867324. View on Pubmed
  33. Olea A, Grochowski J, Luetkemeyer AF, Robb V, Saberi P. Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection. Integr Pharm Res Pract. 2018; 7:105-111. View on Pubmed
  34. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study. Patient Prefer Adherence. 2018; 12:1033-1042. View on Pubmed
  35. Saberi P, Ming K, Dawson-Rose C. What does it mean to be youth-friendly? Results from qualitative interviews with health care providers and clinic staff serving youth and young adults living with HIV. Adolesc Health Med Ther. 2018; 9:65-75. View on Pubmed
  36. Sauceda JA, Neilands TB, Johnson MO, Saberi P. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2018 03; 22(3):939-947. View on Pubmed
  37. Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1). View on Pubmed
  38. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 01 06; 66(2):213-219. View on Pubmed
  39. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e101-e103. View on Pubmed
  40. Sauceda JA, Johnson MO, Saberi P. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 11; 20(11):2624-2628. View on Pubmed
  41. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 11; 30(11):497-505. View on Pubmed
  42. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 06; 30(6):254-60. View on Pubmed
  43. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 06; 17:68. View on Pubmed
  44. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015; 27(10):1275-8. View on Pubmed
  45. Saberi P, Johnson MO. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. View on Pubmed
  46. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. View on Pubmed
  47. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. View on Pubmed
  48. Saberi P, Mayer K, Vittinghoff E, Naar-King S, Adolescent Medicine Trials Network for HIV/AIDS Interventions . Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. View on Pubmed
  49. Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. View on Pubmed
  50. Parya Saberi, Torsten B. Neilands, Mallory O. Johnson. Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014 Jul 1; 13(4):300-304. View on Pubmed
  51. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. View on Pubmed
  52. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014 May 01; 16(5):e117. View on Pubmed
  53. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. View on Pubmed
  54. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. View on Pubmed
  55. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. View on Pubmed
  56. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. View on Pubmed
  57. Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. View on Pubmed
  58. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. View on Pubmed
  59. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. View on Pubmed
  60. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. View on Pubmed
  61. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. . 2012 Sep 01; 61(1):e3-6. View on Pubmed
  62. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. View on Pubmed
  63. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. View on Pubmed
  64. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. View on Pubmed
  65. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. View on Pubmed
  66. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. View on Pubmed
  67. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. View on Pubmed
  68. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. View on Pubmed
  69. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. View on Pubmed
  70. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5.
  71. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6.
  72. June Riedlinger, Niamh Higgins, Parya Saberi. A Rainforest Expedition with The Student Rainforest Fund. Journal of Herbal Pharmacotherapy. 2005 Jan 1; 5(3):103-105.